[Digitization ad modum the Norwegian Medicines Agency].
Lars
L
Slørdal
Anne Elise
AE
Eggen
D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000009:adverse effects*; D004074:Digitoxin / Q000008:administration & dosage / Q000009:adverse effects*; D004077:Digoxin / Q000008:administration & dosage / Q000009:adverse effects*; D057915:Drug Substitution / Q000009:adverse effects*; D006801:Humans; D009664:Norway; D017410:Practice Guidelines as Topic
D000889:Anti-Arrhythmia Agents; D004077:Digoxin; D004074:Digitoxin